Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.62
Delayed Data
As of Feb 27
 -0.05 / -2.99%
Today’s Change
0.97
Today|||52-Week Range
2.12
-14.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
AssetsCash6.4M28.6M9.1M32.9M
 
 
 
 
 
Short Term Investment Cash780.7K22.2M-19.5M23.8M
 
 
 
 
 
Cash & Short Term Investments6.4M28.6M9.1M32.9M
 
 
 
 
 
 
ReceivablesReceivables2.0M15.8K17.6K1.2M
 
 
 
 
 
 
InventoriesInventories1.5M821.5K297.5K2.2M
 
 
 
 
 
 
Current AssetsOther Current Assets305.8K565.2K1.2M1.0M
 
 
 
 
 
Current Assets10.2M30.0M10.6M37.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.4M1.4M2.0M3.6M
 
 
 
 
 
Depreciation-1.9M-978.0K-1.1M-1.5M
 
 
 
 
 
Intangible Assets102.7K85.4K92.5K136.9K
 
 
 
 
 
Other Assets110.1K684.1K420.4K860.0K
 
 
 
 
 
Total Assets10.9M31.2M12.0M40.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.5M681.8K1.4M2.4M
 
 
 
 
 
Short Term Debt71.0K5.6K2.8M4.1M
 
 
 
 
 
Accrued Expenses769.9K1.1M1.3M3.6M
 
 
 
 
 
Other Current Liabilities2.0M1.7M1.3M3.6M
 
 
 
 
 
Other Liabilities3.9M3.3M6.2M11.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.006.5M6.9M23.6M
 
 
 
 
Other Liabilities2.1M257.3K257.1K9.5M
 
 
 
 
 
Total Liabilities6.7M10.1M13.4M44.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock11.0010.007.008.00
 
 
 
 
 
Common Equity4.1M21.1M-1.4M-4.0M
 
 
 
 
 
Total Shareholder Equity4.1M21.1M-1.4M-4.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding86.3M95.4M113.0M135.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account